|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/07/14 Cipher Pharmaceuticals Inc 40FR12B 84:13M Merrill Corp-MD/FA |
Document/Exhibit Description Pages Size
1: 40FR12B Registration of Securities of a Canadian Issuer -- HTML 97K
SEA'34 §12(b)
2: EX-99.01 Miscellaneous Exhibit HTML 31K
3: EX-99.02 Miscellaneous Exhibit HTML 376K
4: EX-99.03 Miscellaneous Exhibit HTML 154K
5: EX-99.04 Miscellaneous Exhibit HTML 44K
6: EX-99.05 Miscellaneous Exhibit HTML 61K
7: EX-99.06 Miscellaneous Exhibit HTML 317K
8: EX-99.07 Miscellaneous Exhibit HTML 32K
9: EX-99.08 Miscellaneous Exhibit HTML 32K
10: EX-99.09 Miscellaneous Exhibit HTML 23K
11: EX-99.10 Miscellaneous Exhibit HTML 557K
12: EX-99.11 Miscellaneous Exhibit HTML 28K
13: EX-99.12 Miscellaneous Exhibit HTML 444K
14: EX-99.13 Miscellaneous Exhibit HTML 27K
15: EX-99.14 Miscellaneous Exhibit HTML 29K
16: EX-99.15 Miscellaneous Exhibit HTML 45K
17: EX-99.16 Miscellaneous Exhibit HTML 27K
18: EX-99.17 Miscellaneous Exhibit HTML 264K
19: EX-99.18 Miscellaneous Exhibit HTML 131K
20: EX-99.19 Miscellaneous Exhibit HTML 28K
21: EX-99.20 Miscellaneous Exhibit HTML 28K
22: EX-99.21 Miscellaneous Exhibit HTML 44K
23: EX-99.22 Miscellaneous Exhibit HTML 41K
24: EX-99.23 Miscellaneous Exhibit HTML 25K
25: EX-99.24 Miscellaneous Exhibit HTML 344K
26: EX-99.25 Miscellaneous Exhibit HTML 169K
27: EX-99.26 Miscellaneous Exhibit HTML 29K
28: EX-99.27 Miscellaneous Exhibit HTML 29K
29: EX-99.28 Miscellaneous Exhibit HTML 40K
30: EX-99.29 Miscellaneous Exhibit HTML 27K
31: EX-99.30 Miscellaneous Exhibit HTML 35K
32: EX-99.31 Miscellaneous Exhibit HTML 351K
33: EX-99.32 Miscellaneous Exhibit HTML 174K
34: EX-99.33 Miscellaneous Exhibit HTML 28K
35: EX-99.34 Miscellaneous Exhibit HTML 28K
36: EX-99.35 Miscellaneous Exhibit HTML 41K
37: EX-99.36 Miscellaneous Exhibit HTML 23K
38: EX-99.37 Miscellaneous Exhibit HTML 23K
39: EX-99.38 Miscellaneous Exhibit HTML 24K
40: EX-99.39 Miscellaneous Exhibit HTML 28K
41: EX-99.40 Miscellaneous Exhibit HTML 406K
42: EX-99.41 Miscellaneous Exhibit HTML 173K
43: EX-99.42 Miscellaneous Exhibit HTML 45K
44: EX-99.43 Miscellaneous Exhibit HTML 40K
45: EX-99.44 Miscellaneous Exhibit HTML 42K
46: EX-99.45 Miscellaneous Exhibit HTML 29K
47: EX-99.46 Miscellaneous Exhibit HTML 28K
48: EX-99.47 Miscellaneous Exhibit HTML 310K
49: EX-99.48 Miscellaneous Exhibit HTML 32K
50: EX-99.49 Miscellaneous Exhibit HTML 32K
51: EX-99.50 Miscellaneous Exhibit HTML 559K
52: EX-99.51 Miscellaneous Exhibit HTML 27K
53: EX-99.52 Miscellaneous Exhibit HTML 424K
54: EX-99.53 Miscellaneous Exhibit HTML 26K
55: EX-99.54 Miscellaneous Exhibit HTML 264K
56: EX-99.55 Miscellaneous Exhibit HTML 156K
57: EX-99.56 Miscellaneous Exhibit HTML 29K
58: EX-99.57 Miscellaneous Exhibit HTML 29K
59: EX-99.58 Miscellaneous Exhibit HTML 44K
60: EX-99.59 Miscellaneous Exhibit HTML 28K
61: EX-99.60 Miscellaneous Exhibit HTML 35K
62: EX-99.61 Miscellaneous Exhibit HTML 32K
63: EX-99.62 Miscellaneous Exhibit HTML 33K
64: EX-99.63 Miscellaneous Exhibit HTML 29K
65: EX-99.64 Miscellaneous Exhibit HTML 33K
66: EX-99.65 Miscellaneous Exhibit HTML 340K
67: EX-99.66 Miscellaneous Exhibit HTML 195K
68: EX-99.67 Miscellaneous Exhibit HTML 29K
69: EX-99.68 Miscellaneous Exhibit HTML 29K
70: EX-99.69 Miscellaneous Exhibit HTML 46K
71: EX-99.70 Miscellaneous Exhibit HTML 354K
72: EX-99.71 Miscellaneous Exhibit HTML 202K
73: EX-99.72 Miscellaneous Exhibit HTML 29K
74: EX-99.73 Miscellaneous Exhibit HTML 29K
75: EX-99.74 Miscellaneous Exhibit HTML 44K
76: EX-99.75 Miscellaneous Exhibit HTML 23K
77: EX-99.76 Miscellaneous Exhibit HTML 369K
78: EX-99.77 Miscellaneous Exhibit HTML 32K
79: EX-99.78 Miscellaneous Exhibit HTML 32K
80: EX-99.79 Miscellaneous Exhibit HTML 23K
81: EX-99.80 Miscellaneous Exhibit HTML 425K
82: EX-99.81 Miscellaneous Exhibit HTML 32K
83: EX-99.82 Miscellaneous Exhibit HTML 32K
84: EX-99.83 Miscellaneous Exhibit HTML 22K
Exhibit 99.60
99.60 Report of Voting Results of 2014 Annual Meeting
Cipher Pharmaceuticals Inc.
Voting Results
(Section 11.3 of National Instrument 51-102)
This report describes the matters voted upon and the outcome of the votes
at the Annual and Special Meeting of Cipher Pharmaceuticals Inc.
(the “Corporation”) held on May 2, 2014
|
|
|
|
|
Number |
| ||||
|
Brief Description of |
|
Outcome |
|
of Votes Cast |
| ||||
|
Matters Voted Upon |
|
of the Vote |
|
For |
|
Against |
|
Withheld |
|
|
In respect to the election of directors |
|
Approved |
|
|
|
|
|
|
|
|
(a) Gerald P. McDole |
|
|
|
14,147,249 |
|
|
|
11,976 |
|
|
(b) Dr. John D. Mull |
|
|
|
14,141,729 |
|
|
|
17,496 |
|
|
(d) Stephen R. Wiseman |
|
|
|
14,147,249 |
|
|
|
11,976 |
|
|
(e) Dr. Stefan Aigner |
|
|
|
14,148,249 |
|
|
|
10,976 |
|
|
(f) Dr. William D. Claypool |
|
|
|
14,148,249 |
|
|
|
10,976 |
|
|
(g) Thomas G. Wellner |
|
|
|
14,147,349 |
|
|
|
11,876 |
|
|
In respect of appointment of auditors |
|
Approved |
|
14,792,989 |
|
|
|
926 |
|
| This ‘40FR12B’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/7/14 | F-X | ||
| 5/2/14 | ||||
| List all Filings | ||||